Australian IVD Framework Proposal Would Broaden Regulatory Oversight
This article was originally published in The Gray Sheet
Executive Summary
Australia's proposed regulatory structure for in vitro diagnostic devices would bring new regulatory requirements and costs for a number of products that currently are exempt from oversight
You may also be interested in...
Blood And Tissue Screening Tests Top Australia’s IVD Regulatory Scheme
In vitro diagnostics that screen for pathogens in the blood supply or in organ and tissue donations would be regulated as highest-risk Class IV devices under the regulatory framework for IVDs proposed by Australia's Therapeutic Goods Administration (TGA)
Blood And Tissue Screening Tests Top Australia’s IVD Regulatory Scheme
In vitro diagnostics that screen for pathogens in the blood supply or in organ and tissue donations would be regulated as highest-risk Class IV devices under the regulatory framework for IVDs proposed by Australia's Therapeutic Goods Administration (TGA)
Certain Aussie Home-Use IVDs Subject To Full Safety Evaluation – TGA
Sponsors of home-use in vitro diagnostics intended for the identification or monitoring of serious conditions will need to demonstrate that lay users are able to obtain comparable results to trained professionals, according to recently-released draft guidelines issued by Australia's Therapeutics Goods Administration